Table 6

Fasting blood glucose levels: effectiveness of treatments

Blood glucose (mean mg/dL)

Change (%)


Initial

4 weeks

8 weeks

10 weeks

4 Weeks-Initial

8 Weeks-Initial

10 Weeks-Initial


Placebo

79.43 ± 11.63

78.34 ± 10.41

76.53 ± 10.42

77.32 ± 8.90

-1.37

-3.67

-2.65

CQ

80.32 ± 8.45

71.56 ± 5.28a

70.30 ± 9.40a

68.38 ± 7.78b

-10.90

-12.47

-14.85

CQ-IG

87.68 ± 6.32

68.32 ± 11.11b *

65.47 ± 8.31b *

60.11 ± 4.31b **

-22.07

-25.32

-31.44


ap < 0.05; bp < 0.001; cp < 0.0001 compared with Placebo

*p < 0.05; **p < 0.001; ***p < 0.0001 compared with CQ

p < 0.05; p < 0.001 compared with Initial; intra-group analysis

Oben et al. Lipids in Health and Disease 2008 7:12   doi:10.1186/1476-511X-7-12

Open Data